chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Student stated she felt itchy, nauseous, felt like she had an ice cube in her throat. Her BP was 140/90 x 2. She was given 50 mg diphenhydramine IM @ 9:40 AM. Her mother took her to the ED.
Moderna COVID-19 Vaccine EUA.  The first day was a sore arm at injection site. Day 2: sore are  and myalgia. Day 3: nausea, fatigue, diarrhea. Day 4: nausea, fatigue, diarrhea, voice became raspy and horse needed constant clearing and congestion. Day 5: nausea, fatigue and congestion. Day 6: nausea, fatigue and congestion.
Pt called to report that he had a fever of 100F on Friday night and had symptoms of dizziness and chills and congestion throughout the day on Friday.  He also has some soreness at the injection site.  He said that he was feeling better today, but still had some congestion.  He said he took a walk for nearly an hour today with no issues.     He stated that he was given Shingrix on 7/1/20 in the afternoon and wondered whether the vaccination caused the symptoms.  Told him I was unsure and that it may be a good idea to get evaluated by his Dr.  He said his Dr was closed and that he was going to call urgent care for advice.
Eyes puffy; Feet puffy/Hands puffy; This spontaneous case was reported by a consumer and describes the occurrence of EYE SWELLING (Eyes puffy) and PERIPHERAL SWELLING (Feet puffy/Hands puffy) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EYE SWELLING (Eyes puffy) and PERIPHERAL SWELLING (Feet puffy/Hands puffy). At the time of the report, EYE SWELLING (Eyes puffy) and PERIPHERAL SWELLING (Feet puffy/Hands puffy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.  On 04-Mar-2021, the patient had their first dose of vaccine. The patient reported that their eyes, hands and feet were puffy.  Reportedly, it was getting better.  No Concomitant product use was reported. No treatment information was provided.
Fluzone administered at 08:45AM. Client started c/o chest tightness and difficulty swallowing.  Refused Epi. Client thought it could be an anxiety attack.  9:55AM client stated tongue tasted like copper.  Again refused Epi.  Friend arrived to pick up client.  Transported to urgent care center.
On 02/22/2021, I had a mammogram scheduled and during that examination, there was a lump discovered in my right breast. I was referred to a specialist where they performed an ultrasound and another mammogram, and they were able to determine the lump was benign.
I got 3 cold sores after the second shot. They went away and I got two more
About 10 minutes in I  started itching at the sight, sore throat, muscle pain at the sight about 15 minutes into shot fatigue set in, I had a headache, really bad like a migraine and I don't get migraines. i laid down and took Tylenol.
MOTHER REPORTED 8-7-15 THAT CHILD DEVELOPED A APPROX QUARTER-SIZED SWOLLEN, HARD, RED "LUMP" UNDER VACCINE SITE TO (L) LEG.  REPORTED WAS WARM TO THE TOUCH.
Patient states she had lightheadedness, s/p booster Pfizer vaccine today, approximately 30 minutes after vaccine.  Patient has multiple allergies.
No adverse event; They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042J21A and 939902) for COVID-19 prophylaxis.     No Medical History information was reported.   On 22-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.).    No concomitant medications were reported. It was reported that lot 042J21A should have been reported with a BUD of Feb 17, 2022. No treatment medications were reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-704416, US-MODERNATX, INC.-MOD-2023-704486 (Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Livefollow up: Updated narrative.; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-704416:Master case US-MODERNATX, INC.-MOD-2023-704486:dose 4 (bivalent drug)
This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. The patient's medical history, drug reactions or allergies and concurrent conditions were not reported. On 18-OCT-2015, the patient was vaccinated with a dose of improperly store (incorrect product storage) RECOMBIVAX HB, lot number L016427, expiration date 13-APR-2017, (dose, route and anatomical location were not reported). No adverse effect was reported. There was no concomitant medication reported. This is one of several reports from the same source. Additional information has been requested.
rt arm shoulder to elbow-wide as blood pressure cuff poss 4-5" wide band of red, swollen & sore;yesterday PM started;got bigger overnoc;painful & itchy;cool compress & APAP;
Information has been received from a healthcare worker (operations manager) referring to unknown number of patients. On unknown dates, the patients were administered improperly stored ROTATEQ, lot # K010323, expiry date: 10-MAY-2016, (route, dose and frequency were not reported). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Very sore at site of injection.  Recommended putting ice on the location, which she did...I followed up with her on the morning of 9/24/2014.  She said the arm was feeling better and didn't have further issues.
hives in throat (20 min post vaccine)  20 min-4 hours post vaccine shortness of breath body itching throat feeling constricted  Sore throat continues as of today
pt recvd vax in 1991 & 24SEP93 lab eval revealed a neg titer for rubella; No further details were provided;
Pt recvd 1 dose of Engerix-B & devel occipital h/a & tingling of fingers 4-6 hrs p/vax; sx subsided w/in 24 hrs & now OK;
Approximately 2 -3 weeks after my 2nd dose vaccination I experienced the following symptoms: Shoulder joint pain. Mostly happened when I was sleeping and the pain was severe enough that it wakes me up at night. I took Ibuprofen for treatment and it did not help improve my shoulder pain. I thought it was due to my age but then I saw an orthopedic surgeon and did an MRI and turns out I have torn tendon in my left shoulder. As of today 05/18/2022 I am still not completely healed and have not fully recovered that's why I am seeing another doctor this coming May 29.
PAIN, ITCHING, REDNESS, SWELLING, WARMTH AND INDURATION AT SITE  SITE OF INJECTION.  SHE HAS HAD NO RELIEF FROM REGULAR LISTED PAIN MEDICATION INCLUDING NORCO 5MG AND VOLTAREN XR 100MG.
The next morning, I woke up with a fever 98.8 and was nauseated. That afternoon, I started having sharp, stabbing pains in my thigh. I could not get an ultrasound (was concerned about blood clots) at our doctor's office, so I went to the Emergency Room of the local hospital. They did not find a blood clot, so they gave me some Tylenol and sent me home. The next day, the pain was gone, and I felt better, However, a week later, there was a rash on my face, and my eyelids were "itchy", so, for two nights, I took Benadryl (the morning after I had the shot, my face was flushed).  Monday morning, I called my doctor and reportd my reaction.
Upset stomach; Low temperature; Shivering; Chills; Soreness at the site of the injection Left arm; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (Upset stomach), BODY TEMPERATURE DECREASED (Low temperature), INJECTION SITE PAIN (Soreness at the site of the injection Left arm), CHILLS (Shivering) and CHILLS (Chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced INJECTION SITE PAIN (Soreness at the site of the injection Left arm). On 30-Mar-2021, the patient experienced ABDOMINAL DISCOMFORT (Upset stomach), BODY TEMPERATURE DECREASED (Low temperature), CHILLS (Shivering) and CHILLS (Chills). At the time of the report, ABDOMINAL DISCOMFORT (Upset stomach), BODY TEMPERATURE DECREASED (Low temperature), INJECTION SITE PAIN (Soreness at the site of the injection Left arm), CHILLS (Shivering) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 96.3 f (Inconclusive) 96.3 F and 96.8 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medicines were reported. No treatment information were reported.
This spontaneous report was received from a healthcare worker regarding to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. On 23-FEB-2016 the patient was vaccinated with PNEUMOVAX 23 vial 25/0.5 microgram/milliliter (mcg/ml) 1 standard package vial of 2.5, lot details and dosage regimen unknown. After the dose was administered it was realized that the patient had previously received a dose of PNEUMOVAX 23 on 06-FEB-2016. No adverse effects were reported. Product quality complaint (PQC) was not filed. Additional information has been requested.
103F fever (2hrs) 99+ Fever for 18 hours after injection (took Tylenol) Left arm (injection arm) limited mobility  (3/3-3/5) Chills (24 hrs) Whole body aches (24hrs) Muscle aches (24hrs) Nausea (24hrs) Lightheaded (24hrs) Dizzy (24hrs)
Pregnant; This spontaneous prospective pregnancy case was reported by an other health care professional and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnant) in a 26-year-old female patient (gravida 3, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037K20A and 032L20A) for COVID-19 vaccination.     The patient's past medical history included Latex allergy, Polycystic ovarian syndrome, Pregnancy on 09-Jan-2014 and Pregnancy (Live, full term birth) on 02-May-2018. Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication.   On 24-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 22-Sep-2021. On 21-Jan-2021, the patient experienced EXPOSURE DURING PREGNANCY (Pregnant). On 21-Jan-2021, EXPOSURE DURING PREGNANCY (Pregnant) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information were reported.  Previous pregnancies included first pregnancy ended on 09-Jan-2014 with no outcome details and second pregnancy was ended on 02-May-2018 with full-term live birth as outcome without any complications.; Sender's Comments: This is a case of product exposure during pregnancy with no associated AEs for this female patient. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.
pt recvd vax;myalgias, joint pain; rash reported by pt but not seen;
Trouble breathing through nose and mouth, went to get inhaler got dizzy and felt nauseous.  Used inhaler, nose spray, breathed in paper bag and sat for a while and felt better about 1-2 hours later.
Uncontrollable crying for 3 hours straight. DTaP shot was administered 6:30 PM on 5/29/03. Reaction occurred around 4:30 PM 5/31/03.
This spontaneous report as received from a Licensed Practical Nurse (L.P.N.) refers to a patient of unknown age and gender. Medical history and concurrent conditions were not provided. On 30-OCT-2015, the patient was vaccinated with an expired and improperly stored dose of improperly stored dose of PNEUMOVAX23 lot # K004542, expiration date: 19-AUG-2015 (dose and route were not reported). No adverse effect reported or Product Quality Complaints (PQC) involved. There was no concomitant medication provided. This is one of three reports received from the same reporter. Additional information has been requested.
Itchy rash has covered a large portion of my body starting a couple of weeks after receiving my Pfizer booster shot.  I have no reactions for the first two vaccines, but within a couple of weeks after receiving the booster I began to break out in a rash.  I have been on 4 rounds of prednisone since the booster shot and each time it clears up, but comes back worse after a few days of not being on the medication.  I had no allergies or allergic reactions to any vaccine previously.  It has become a life-affecting issue and my dermatologist is unable to figure out how to help me.
facial herpes outbreaks; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (facial herpes outbreaks) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Dec-2021, the patient experienced HERPES ZOSTER (facial herpes outbreaks). At the time of the report, HERPES ZOSTER (facial herpes outbreaks) outcome was unknown.            Concomitant medication was not provided.  Treatment information was not provided.
She received seasonal flu vaccine on 10/2/2009 in the right arm. On 10/14/2009 she experienced swelling and achiness in the right arm. She also had a fever, chills, malaise, fatigue, insomnia, irritability, difficulty breathing, shortness of breath, runny nose, chest pain, pain in arms and legs, palpitations, dizziness, abdominal pain, diarrhea, numbness or tingling in limbs. As she has a history of a DVT in the right arm she went to see the doctor. Tests for DVT in the right arm came back negative. Flu testing came back positive for Paraflu One, she received on dose of TAMIFLU. She still felt a little crummy on 10/22/2009.  Follow-up receives states - RE: Missing information letter dated 1/20/2010 - Unfortunately, this information is not available to us. Wehave contacted this patient an he or she agreed to share his or her contact information to VAERS - Pt contact info updated.
Pt recvd series of 3 Engerix-B vax & failed to seroconvert to Hep B surface antibody positive; six month dose was given MAR91; 15MAY91 lab test neg for Hep B surface antibodies;
Lump and soreness on the vaccination site; Very hot to touch; Lump and soreness on the vaccination site; Hardness in her arm; Swelling and hardness in her arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Lump and soreness on the vaccination site), VACCINATION SITE WARMTH (Very hot to touch), VACCINATION SITE INDURATION (Hardness in her arm), VACCINATION SITE SWELLING (Swelling and hardness in her arm) and VACCINATION SITE PAIN (Lump and soreness on the vaccination site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022C21A and 040321A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-May-2021, the patient experienced VACCINATION SITE INDURATION (Hardness in her arm) and VACCINATION SITE SWELLING (Swelling and hardness in her arm). On an unknown date, the patient experienced VACCINATION SITE MASS (Lump and soreness on the vaccination site), VACCINATION SITE WARMTH (Very hot to touch) and VACCINATION SITE PAIN (Lump and soreness on the vaccination site). On 12-May-2021, VACCINATION SITE INDURATION (Hardness in her arm) and VACCINATION SITE SWELLING (Swelling and hardness in her arm) had resolved. At the time of the report, VACCINATION SITE MASS (Lump and soreness on the vaccination site), VACCINATION SITE WARMTH (Very hot to touch) and VACCINATION SITE PAIN (Lump and soreness on the vaccination site) had resolved.            No concomitant medications were reported.  Patient reported shower and eating as treatment. She reported all the events went away after 2.5 days.   This case was linked to MOD-2021-127480 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 15-Jun-2021: Added events and duration of events.
The evening after I received the Moderna booster (which was .5cc as I had JJ single dose in March) my back started to hurt. I assumed it was because I had lifted my dog onto the bed. I had thought vaccine reactions were headaches and fatigue, not backache. I couldn't get comfortable through the night and actually had trouble rolling over. I called telehealth through my insurance company and was prescribed a muscle relaxant. I tried to hold off taking the medication until after work, and as I approached 30 hours my symptoms vanished as quickly as they came. It was then that I realized it was most likely a vaccine reaction.
Mild body ache started approximately 15 hours after vaccination. Took two Ibuprofen. Expect full recovery by morning.
Pain in L deltoid x8 days, s/p TDAP administration at our clinic on 3/6/2019. Pain has been worsening. Pain is worse with motion. L deltoid feels warm and is diffusely TTP. No appreciable swelling. Pt cannot recall where injection site was on arm. No fevers, other joint pains. No discharge, streaking. No Hx negative vaccine reaction. Has been taking 800-100mg ibu q6h for pain - limitedly effective.
This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions and concomitant therapies were not reported. On 02-OCT-2017, the patient was vaccinated with improperly stored dose of ZOSTAVAX lot# N015628 and expiration date 30-JUL-2018 (dose and route of administration were not reported) reconstituted with sterile diluent, lot# N008379 and expiration date 14-NOV-2019. There were no adverse effects reported. Administered dose of vaccine experienced the temperature excursion from 15 to 46 degrees Fahrenheit for 16 hours 41 minutes. There was previous excursion reported, 15 to 46 (39.5) degrees Fahrenheit for 21 hours. Data logger was involved. Sterile diluent was properly stored.
no adverse event; vaccine used which were beyond the 30-Day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine used which were beyond the 30-Day beyond use date) and NO ADVERSE EVENT (no adverse event) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 056m21a) for COVID-19 prophylaxis.     No Medical History information was reported.    On 17-May-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine used which were beyond the 30-Day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (vaccine used which were beyond the 30-Day beyond use date) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (vaccine used which were beyond the 30-Day beyond use date).    Concomitant products were not reported.  It was reported that patient received monovalent dose that was administered beyond 30 day beyond use date. The use by date of lot  056m21a was reported as 12-May-2022.  Treatment medications were not reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Non significant Live Follow up received.; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-704416:Master case
General redness and slight discomfort day of/day after injection. 12/1/15 - redness spread and swelled to approx. size of grapefruit. Pt came into pharmacy for us to check. We told her to use cool compress, Benadryl, etc. and let us know if it worsens and to call 9-1-1 or visit ER if becomes life threatening.